Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Real-World Study of MET Overexpression in Patients With Non-Small Cell Lung Cancer

NCT06068842 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06068842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06068842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Real-World Study of MET Overexpression in Patients With Non-Small Cell Lung Cancer
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
November 3, 2023
Completion date
December 31, 2024
Enrollment
579 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer